SE7415686L - - Google Patents

Info

Publication number
SE7415686L
SE7415686L SE7415686A SE7415686A SE7415686L SE 7415686 L SE7415686 L SE 7415686L SE 7415686 A SE7415686 A SE 7415686A SE 7415686 A SE7415686 A SE 7415686A SE 7415686 L SE7415686 L SE 7415686L
Authority
SE
Sweden
Prior art keywords
compound
carboxylic acid
substituent
arysulphonyloxy
cycloalkylaliphatic
Prior art date
Application number
SE7415686A
Other languages
English (en)
Other versions
SE422211B (sv
Inventor
J Seubert
H Thomas
P Andrews
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5900929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7415686(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SE7415686L publication Critical patent/SE7415686L/xx
Publication of SE422211B publication Critical patent/SE422211B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7415686A 1973-12-17 1974-12-13 Analogiforfarande for framstellning av 2-acyl-4-pyrazino(2,1-a)isokinolin-derivat SE422211B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2362539A DE2362539C2 (de) 1973-12-17 1973-12-17 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
SE7415686L true SE7415686L (en:Method) 1975-06-18
SE422211B SE422211B (sv) 1982-02-22

Family

ID=5900929

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7415686A SE422211B (sv) 1973-12-17 1974-12-13 Analogiforfarande for framstellning av 2-acyl-4-pyrazino(2,1-a)isokinolin-derivat

Country Status (35)

Country Link
US (1) US4001411A (en:Method)
JP (1) JPS5826352B2 (en:Method)
AR (2) AR208527A1 (en:Method)
AT (1) AT346334B (en:Method)
BE (1) BE823400A (en:Method)
CA (1) CA1036606A (en:Method)
CH (3) CH612195A5 (en:Method)
CS (1) CS241002B2 (en:Method)
DD (1) DD115908A5 (en:Method)
DE (1) DE2362539C2 (en:Method)
DK (1) DK141845C (en:Method)
ES (2) ES432974A1 (en:Method)
FI (1) FI59594C (en:Method)
FR (1) FR2254343B1 (en:Method)
GB (1) GB1441554A (en:Method)
GR (1) GR60708B (en:Method)
GT (1) GT197850798A (en:Method)
HK (1) HK13379A (en:Method)
HU (1) HU170858B (en:Method)
IE (1) IE40124B1 (en:Method)
IL (1) IL46162A (en:Method)
IN (1) IN139511B (en:Method)
IT (1) IT7851978A0 (en:Method)
KE (1) KE2946A (en:Method)
LU (1) LU71204A1 (en:Method)
NL (1) NL185406C (en:Method)
NO (1) NO142304C (en:Method)
OA (1) OA04868A (en:Method)
PH (1) PH14220A (en:Method)
PL (3) PL99105B1 (en:Method)
RO (1) RO66907A (en:Method)
SE (1) SE422211B (en:Method)
SU (3) SU631070A3 (en:Method)
YU (1) YU41288B (en:Method)
ZA (1) ZA747253B (en:Method)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141978A (en) * 1973-12-17 1979-02-27 Merck Patent Gesellschaft Mit Beschrankter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4196291A (en) * 1973-12-17 1980-04-01 Merck Patent Gesellschaft Mit Beschraenkter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4162319A (en) * 1974-08-28 1979-07-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Ring substituted pyrazino-isoquinoline derivatives and their preparation
US4120961A (en) * 1974-08-28 1978-10-17 E. Merck Ring substituted pyrazino-isoquinoline derivatives and their preparation
DE2441261A1 (de) * 1974-08-28 1976-03-18 Merck Patent Gmbh Ringsubstituierte pyrazino-isochinolin-derivat und verfahren zu ihrer herstellung
DE2841668A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
US4303659A (en) 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
FR2520740A1 (fr) * 1982-01-29 1983-08-05 Sanofi Sa Procede pour la preparation d'acyl-2-hexahydro-1,3,4,6,7,11b-2h-pyrazino (2,1-a) isoquinoleinones-4 et intermediaires
EP0134984B1 (en) * 1983-07-16 1988-07-13 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
GB9321854D0 (en) * 1993-10-22 1993-12-15 Zeneca Ltd Pyridazino quinoline compounds
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US6429211B1 (en) 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
KR100682506B1 (ko) * 2005-01-18 2007-02-15 (주)젠크로스 프라지콴텔, 또는 이의 염을 포함하는 약학 조성물
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
AR054380A1 (es) * 2005-06-09 2007-06-20 Schering Plough Ltd Control de parasitos en animales con derivados de n- ((feniloxi) fenil) -1,1,1-trifluorometansulfonamida y de n-(fenilsulfanil) fenil) -1,1,1-trifluorometansulfonamida
FR2912145B1 (fr) * 2007-02-02 2009-03-06 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITPD20070274A1 (it) * 2007-08-08 2009-02-09 Sanypet S P A Crocchetta per animali e metodo per la sua produzione
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
CN102093346B (zh) * 2010-03-16 2012-09-05 浙江金伯士药业有限公司 一种吡喹酮的制备方法
WO2012122028A2 (en) 2011-03-04 2012-09-13 Concert Pharmaceuticals Inc. Pyrazinoisoquinoline compounds
CN103910725B (zh) * 2013-01-09 2015-12-02 江南大学 一类吡喹酮类似物、其制备方法和用途

Also Published As

Publication number Publication date
KE2946A (en) 1979-04-12
FI59594C (fi) 1981-09-10
US4001411A (en) 1977-01-04
NO744521L (en:Method) 1975-07-14
CH612195A5 (en:Method) 1979-07-13
AR208715A1 (es) 1977-02-28
AT346334B (de) 1978-11-10
DD115908A5 (en:Method) 1975-10-20
IL46162A (en) 1979-01-31
FR2254343B1 (en:Method) 1978-06-30
NL185406B (nl) 1989-11-01
FR2254343A1 (en:Method) 1975-07-11
SU668603A3 (ru) 1979-06-15
NO142304B (no) 1980-04-21
ES432974A1 (es) 1977-02-16
BE823400A (fr) 1975-06-16
OA04868A (fr) 1980-10-31
ZA747253B (en) 1975-11-26
DE2362539A1 (de) 1975-08-28
RO66907A (ro) 1981-06-26
DK654274A (en:Method) 1975-08-25
HK13379A (en) 1979-03-23
HU170858B (hu) 1977-09-28
FI363274A7 (en:Method) 1975-06-18
DK141845C (da) 1980-12-22
GR60708B (en) 1978-07-24
PH14220A (en) 1981-04-02
NO142304C (no) 1980-07-30
AR208527A1 (es) 1977-02-15
LU71204A1 (en:Method) 1975-04-17
JPS5826352B2 (ja) 1983-06-02
DE2362539C2 (de) 1986-05-07
IE40124L (en) 1975-06-17
IN139511B (en:Method) 1976-06-26
YU336174A (en) 1983-01-21
CS842774A2 (en) 1985-06-13
IT7851978A0 (it) 1978-11-20
SE422211B (sv) 1982-02-22
JPS5093999A (en:Method) 1975-07-26
SU631070A3 (ru) 1978-10-30
AU7643874A (en) 1976-06-17
GB1441554A (en) 1976-07-07
YU41288B (en) 1987-02-28
NL185406C (nl) 1990-04-02
PL99088B1 (pl) 1978-06-30
ES441546A1 (es) 1977-04-16
FI59594B (fi) 1981-05-29
PL99105B1 (pl) 1978-06-30
SU625613A3 (ru) 1978-09-25
NL7416432A (nl) 1975-06-19
CH620442A5 (en:Method) 1980-11-28
CH621788A5 (en:Method) 1981-02-27
GT197850798A (es) 1979-08-01
IE40124B1 (en) 1979-03-14
DK141845B (da) 1980-06-30
ATA996274A (de) 1978-03-15
PL94074B1 (en:Method) 1977-07-30
CA1036606A (en) 1978-08-15
IL46162A0 (en) 1975-02-10
CS241002B2 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
SE7415686L (en:Method)
GB1325192A (en) Phloroglucinol derivatives
GB1432576A (en) Substituted phenylacetic acids
GB1422295A (en) Indole derivatives
GB1268952A (en) alpha-HALOAMIDES
GB1497382A (en) Carboxylic acids derived from indenofuran and indeno-thiophene derivatives of such compounds methods for preparing them and pharmaceutical compositions containing them
GB1413068A (en) Bromoergolines
GB1490486A (en) 4-imino-1,3-diazobicyclo-(3.1.0)hexan-2-one
GB1496491A (en) Dihydroergopeptine derivatives
GB1390699A (en) Preparation of beta-alkoxy-omega lactams
GB1194598A (en) Benzofuran Derivatives
GB1355991A (en) Unsaturated chemical compounds
GB1352245A (en) Azabicyclo-3.3.1-nonan-3-ol ester derivatives
GB1412546A (en) Morpholine derivatives
GB1396240A (en) Derivatives of 2-hydroxybenzophenone and their use as stabilisers
GB1219387A (en) Bicyclo[2.2.2]oct-2-ene-amino acid compounds
SE7403907L (en:Method)
GB1289227A (en:Method)
GB1397434A (en) Evomonoside derivatives
GB1301367A (en:Method)
GB1236634A (en) New pyrimidine derivatives
GB1252248A (en:Method)
SE7408868L (en:Method)
GB1369578A (en) Pharmaceutical compositions containing indole-caboxylic acid derivatives
GB1284423A (en) Cyclohexa-1,4-diene-1-acetic acids

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7415686-0

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7415686-0

Format of ref document f/p: F